You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Drug

Published Date: 01 Aug 2025

Revision Summary:
Drug Monograph: Updated Supplementary Public Funding section
Aug 2025
Drug

Published Date: 01 Aug 2025

Revision Summary:
Drug Monograph: Updated Dosing, Administration and Supplementary Public Funding sections
Aug 2025
Regimen
Published Date: 31 Jul 2025
Cancer Type:
Hematologic, 
Leukemia - Chronic Myeloid (CML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated to a full regimen monograph

Jul 2025
Regimen
Published Date: 23 Jul 2025
Cancer Type:
Genitourinary, 
Prostate
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

Jul 2025
Regimen
Published Date: 23 Jul 2025
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplemental Public Funding, and Drug Regimen sections

Jul 2025
Regimen
Published Date: 23 Jul 2025
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplemental Public Funding, and Drug Regimen sections

Jul 2025
Regimen
Published Date: 23 Jul 2025
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplemental Public Funding, and Drug Regimen sections

Jul 2025
Regimen
Published Date: 23 Jul 2025
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplemental Public Funding, and Drug Regimen sections

Jul 2025
Regimen
Published Date: 23 Jul 2025
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplemental Public Funding, and Drug Regimen sections

Jul 2025
Regimen
Published Date: 22 Jul 2025
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

Jul 2025
Regimen
Published Date: 22 Jul 2025
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL), 
Leukemia - Chronic Lymphocytic (CLL), 
Leukemia - Hairy Cell, 
Lymphoma - Hodgkin, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade, 
Lymphoma - Non-Hodgkin's Low Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative, Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

Jul 2025
Regimen
Published Date: 22 Jul 2025
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Curative, Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

Jul 2025

Pages